HART
ETF
HART
·
UNKNOWN
·
64 holdings
About HART
No description available for this ETF.
Fund Details
- Expense Ratio
- —
- Inception Date
- —
- Exchange
- UNKNOWN
- Currency
- USD
- Holdings As Of
- Apr 10, 2026
- Tracked Holdings
- 68.8%
- HHI Score
- 350,97
- Top Sector
- Healthcare (54.414847%)
Performance
Low (15,2%)
↗ Accelerating
1W
▲ 4,50%
1M
▲ 2,20%
3M
▲ 5,03%
6M
▼ -5,98%
YTD
▲ 0,07%
1Y
▼ -5,28%
3Y
▲ 10,80%
1W return (+4.5%) exceeds 1M (+2.2%) — momentum is building
Concentration Risk
51,52%
Moderately Concentrated
Diversified
Concentrated
The top 10 holdings represent 51,52% of the fund. This ETF is heavily concentrated — performance is largely driven by a few stocks.
Top Holdings Today
GOOGL
▲ 0,40%
JNJ
▲ 0,60%
AZN
▲ 0,61%
AAPL
▲ 0,17%
LLY
▲ 0,57%
BSX
▼ -2,15%
PFE
▼ -0,22%
ABT
▼ -0,76%
UNH
▲ 0,09%
Weighted avg. of top holdings
▼ -0,06%
Sector Allocation
Healthcare
54,41%
Consumer Cyclical
6,97%
Technology
6,51%
Communication Services
5,74%
Financial Services
3,44%
Industrials
1,66%
ETF
1,08%
Consumer Defensive
0,91%
Retail Trade
0,63%
Top 10 Holdings
All Holdings (64)
Top 10: 51,52% of fund| # | Ticker | Name | Weight | Shares | Market Value |
|---|---|---|---|---|---|
| 1 | GOOGL | Alphabet Inc | 5,74% | 2 594 | 497 788,6 |
| 2 | JNJ | Johnson & Johnson | 5,46% | 2 871 | 472 968,54 |
| 3 | AZN | AstraZeneca PLC | 5,33% | 3 082 | 461 855,44 |
| 4 | AAPL | Apple Inc | 5,31% | 2 218 | 460 390,26 |
| 5 | NOVN | Novartis AG | 5,21% | 3 893 | 451 550,61 |
| 6 | LLY | Eli Lilly & Co | 5,16% | 604 | 447 002,28 |
| 7 | BSX | Boston Scientific Corp | 5,12% | 4 233 | 444 126,36 |
| 8 | PFE | Pfizer Inc | 5,10% | 18 968 | 441 764,72 |
| 9 | ABT | Abbott Laboratories | 4,86% | 3 336 | 420 969,84 |
| 10 | UNH | UnitedHealth Group Inc | 4,25% | 1 476 | 368 350,56 |
Showing top 10 of 64 holdings
·
Listed: 99,59%
·
0,41% in other positions
Related ETFs
{"event":"ticker_viewed","properties":{"ticker":"HART","listing_kind":"etf","pathname":"/etfs/hart","exchange":"UNKNOWN"}}
